Literature DB >> 28069942

A paradox of transcriptional and functional innate interferon responses of human intestinal enteroids to enteric virus infection.

Kapil Saxena1, Lukas M Simon2, Xi-Lei Zeng1, Sarah E Blutt1, Sue E Crawford1, Narayan P Sastri1, Umesh C Karandikar1, Nadim J Ajami1, Nicholas C Zachos3, Olga Kovbasnjuk3, Mark Donowitz3, Margaret E Conner1, Chad A Shaw2, Mary K Estes4.   

Abstract

The intestinal epithelium can limit enteric pathogens by producing antiviral cytokines, such as IFNs. Type I IFN (IFN-α/β) and type III IFN (IFN-λ) function at the epithelial level, and their respective efficacies depend on the specific pathogen and site of infection. However, the roles of type I and type III IFN in restricting human enteric viruses are poorly characterized as a result of the difficulties in cultivating these viruses in vitro and directly obtaining control and infected small intestinal human tissue. We infected nontransformed human intestinal enteroid cultures from multiple individuals with human rotavirus (HRV) and assessed the host epithelial response by using RNA-sequencing and functional assays. The dominant transcriptional pathway induced by HRV infection is a type III IFN-regulated response. Early after HRV infection, low levels of type III IFN protein activate IFN-stimulated genes. However, this endogenous response does not restrict HRV replication because replication-competent HRV antagonizes the type III IFN response at pre- and posttranscriptional levels. In contrast, exogenous IFN treatment restricts HRV replication, with type I IFN being more potent than type III IFN, suggesting that extraepithelial sources of type I IFN may be the critical IFN for limiting enteric virus replication in the human intestine.

Entities:  

Keywords:  enteric virus; human enteroids; human rotavirus; interferon

Mesh:

Substances:

Year:  2017        PMID: 28069942      PMCID: PMC5278484          DOI: 10.1073/pnas.1615422114

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  92 in total

1.  Rotavirus Controls Activation of the 2'-5'-Oligoadenylate Synthetase/RNase L Pathway Using at Least Two Distinct Mechanisms.

Authors:  Liliana Sánchez-Tacuba; Margarito Rojas; Carlos F Arias; Susana López
Journal:  J Virol       Date:  2015-09-23       Impact factor: 5.103

2.  Rotavirus-induced IFN-β promotes anti-viral signaling and apoptosis that modulate viral replication in intestinal epithelial cells.

Authors:  Amena H Frias; Rheinallt M Jones; Nimita H Fifadara; Matam Vijay-Kumar; Andrew T Gewirtz
Journal:  Innate Immun       Date:  2011-07-06       Impact factor: 2.680

3.  Fast gapped-read alignment with Bowtie 2.

Authors:  Ben Langmead; Steven L Salzberg
Journal:  Nat Methods       Date:  2012-03-04       Impact factor: 28.547

Review 4.  Immunity to rotavirus infection in mice.

Authors:  M A Franco; H B Greenberg
Journal:  J Infect Dis       Date:  1999-05       Impact factor: 5.226

5.  Diversity of interferon antagonist activities mediated by NSP1 proteins of different rotavirus strains.

Authors:  Michelle M Arnold; John T Patton
Journal:  J Virol       Date:  2010-12-22       Impact factor: 5.103

6.  Interferon-λ cures persistent murine norovirus infection in the absence of adaptive immunity.

Authors:  Timothy J Nice; Megan T Baldridge; Broc T McCune; Jason M Norman; Helen M Lazear; Maxim Artyomov; Michael S Diamond; Herbert W Virgin
Journal:  Science       Date:  2014-11-27       Impact factor: 47.728

Review 7.  Human enteroids as an ex-vivo model of host-pathogen interactions in the gastrointestinal tract.

Authors:  Jennifer Foulke-Abel; Julie In; Olga Kovbasnjuk; Nicholas C Zachos; Khalil Ettayebi; Sarah E Blutt; Joseph M Hyser; Xi-Lei Zeng; Sue E Crawford; James R Broughman; Mary K Estes; Mark Donowitz
Journal:  Exp Biol Med (Maywood)       Date:  2014-04-09

8.  Rotavirus NSP1 inhibits expression of type I interferon by antagonizing the function of interferon regulatory factors IRF3, IRF5, and IRF7.

Authors:  Mario Barro; John T Patton
Journal:  J Virol       Date:  2007-02-14       Impact factor: 5.103

Review 9.  Regulation of type I interferon responses.

Authors:  Lionel B Ivashkiv; Laura T Donlin
Journal:  Nat Rev Immunol       Date:  2014-01       Impact factor: 53.106

10.  Rotavirus NSP1 Associates with Components of the Cullin RING Ligase Family of E3 Ubiquitin Ligases.

Authors:  Lindy M Lutz; Chandler R Pace; Michelle M Arnold
Journal:  J Virol       Date:  2016-06-10       Impact factor: 5.103

View more
  66 in total

Review 1.  Type III Interferons in Antiviral Defenses at Barrier Surfaces.

Authors:  Alexandra I Wells; Carolyn B Coyne
Journal:  Trends Immunol       Date:  2018-09-12       Impact factor: 16.687

Review 2.  Type III IFNs: Beyond antiviral protection.

Authors:  Sergei V Kotenko; Amariliz Rivera; Dane Parker; Joan E Durbin
Journal:  Semin Immunol       Date:  2019-06       Impact factor: 11.130

Review 3.  Using Diverse Model Systems to Define Intestinal Epithelial Defenses to Enteric Viral Infections.

Authors:  Elisha Segrist; Sara Cherry
Journal:  Cell Host Microbe       Date:  2020-03-11       Impact factor: 21.023

Review 4.  New Age Strategies To Reconstruct Mucosal Tissue Colonization and Growth in Cell Culture Systems.

Authors:  Alyssa C Fasciano; Joan Mecsas; Ralph R Isberg
Journal:  Microbiol Spectr       Date:  2019-03

5.  Reverse Genetics System for a Human Group A Rotavirus.

Authors:  Takahiro Kawagishi; Jeffery A Nurdin; Misa Onishi; Ryotaro Nouda; Yuta Kanai; Takeshi Tajima; Hiroshi Ushijima; Takeshi Kobayashi
Journal:  J Virol       Date:  2020-01-06       Impact factor: 5.103

6.  Adenovirus Infection of Human Enteroids Reveals Interferon Sensitivity and Preferential Infection of Goblet Cells.

Authors:  Mayumi K Holly; Jason G Smith
Journal:  J Virol       Date:  2018-04-13       Impact factor: 5.103

7.  Human norovirus exhibits strain-specific sensitivity to host interferon pathways in human intestinal enteroids.

Authors:  Shih-Ching Lin; Lin Qu; Khalil Ettayebi; Sue E Crawford; Sarah E Blutt; Matthew J Robertson; Xi-Lei Zeng; Victoria R Tenge; B Vijayalakshmi Ayyar; Umesh C Karandikar; Xiaomin Yu; Cristian Coarfa; Robert L Atmar; Sasirekha Ramani; Mary K Estes
Journal:  Proc Natl Acad Sci U S A       Date:  2020-09-09       Impact factor: 11.205

8.  Analysis of tick-borne encephalitis virus-induced host responses in human cells of neuronal origin and interferon-mediated protection.

Authors:  Martin Selinger; Gavin S Wilkie; Lily Tong; Quan Gu; Esther Schnettler; Libor Grubhoffer; Alain Kohl
Journal:  J Gen Virol       Date:  2017-08-08       Impact factor: 3.891

Review 9.  Rotavirus infection.

Authors:  Sue E Crawford; Sasirekha Ramani; Jacqueline E Tate; Umesh D Parashar; Lennart Svensson; Marie Hagbom; Manuel A Franco; Harry B Greenberg; Miguel O'Ryan; Gagandeep Kang; Ulrich Desselberger; Mary K Estes
Journal:  Nat Rev Dis Primers       Date:  2017-11-09       Impact factor: 52.329

10.  An Optimized Reverse Genetics System Suitable for Efficient Recovery of Simian, Human, and Murine-Like Rotaviruses.

Authors:  Liliana Sánchez-Tacuba; Ningguo Feng; Nathan J Meade; Kenneth H Mellits; Philippe H Jaïs; Linda L Yasukawa; Theresa K Resch; Baoming Jiang; Susana López; Siyuan Ding; Harry B Greenberg
Journal:  J Virol       Date:  2020-08-31       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.